Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28


Mesenchymal stem cell repression of Th17 cells is triggered by mitochondrial transfer.

Luz-Crawford P, Hernandez J, Djouad F, Luque-Campos N, Caicedo A, Carrère-Kremer S, Brondello JM, Vignais ML, Pène J, Jorgensen C.

Stem Cell Res Ther. 2019 Aug 1;10(1):232. doi: 10.1186/s13287-019-1307-9.


The role of metabolism and tunneling nanotube-mediated intercellular mitochondria exchange in cancer drug resistance.

Hekmatshoar Y, Nakhle J, Galloni M, Vignais ML.

Biochem J. 2018 Jul 31;475(14):2305-2328. doi: 10.1042/BCJ20170712. Review.


Intercellular mitochondria trafficking highlighting the dual role of mesenchymal stem cells as both sensors and rescuers of tissue injury.

Rodriguez AM, Nakhle J, Griessinger E, Vignais ML.

Cell Cycle. 2018;17(6):712-721. doi: 10.1080/15384101.2018.1445906. Review.


Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy.

Vignais ML, Caicedo A, Brondello JM, Jorgensen C.

Stem Cells Int. 2017;2017:6917941. doi: 10.1155/2017/6917941. Epub 2017 Jun 4. Review.


MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells.

Nzigou Mombo B, Gerbal-Chaloin S, Bokus A, Daujat-Chavanieu M, Jorgensen C, Hugnot JP, Vignais ML.

J Vis Exp. 2017 Feb 22;(120). doi: 10.3791/55245.


IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.

Escobar P, Bouclier C, Serret J, Bièche I, Brigitte M, Caicedo A, Sanchez E, Vacher S, Vignais ML, Bourin P, Geneviève D, Molina F, Jorgensen C, Lazennec G.

Oncotarget. 2015 Oct 6;6(30):29034-47. doi: 10.18632/oncotarget.4732.


MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function.

Caicedo A, Fritz V, Brondello JM, Ayala M, Dennemont I, Abdellaoui N, de Fraipont F, Moisan A, Prouteau CA, Boukhaddaoui H, Jorgensen C, Vignais ML.

Sci Rep. 2015 Mar 13;5:9073. doi: 10.1038/srep09073.


Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion.

Lopez-Mejia IC, De Toledo M, Della Seta F, Fafet P, Rebouissou C, Deleuze V, Blanchard JM, Jorgensen C, Tazi J, Vignais ML.

Mol Biol Cell. 2013 Oct;24(20):3164-76. doi: 10.1091/mbc.E13-03-0142. Epub 2013 Aug 21.


Opposite effects of transforming growth factor-beta activation and rho-associated kinase inhibition on human trophoblast migration in a reconstituted placental-endometrial coculture system.

Fafet P, Rebouissou C, Maudelonde T, Vignais ML.

Endocrinology. 2008 Sep;149(9):4475-85. doi: 10.1210/en.2008-0253. Epub 2008 May 22.


Cell type-dependent control of NF-Y activity by TGF-beta.

Alabert C, Rogers L, Kahn L, Niellez S, Fafet P, Cerulis S, Blanchard JM, Hipskind RA, Vignais ML.

Oncogene. 2006 Jun 8;25(24):3387-96. Epub 2006 Jan 23.


Cyclin A is a mediator of p120E4F-dependent cell cycle arrest in G1.

Fajas L, Paul C, Vié A, Estrach S, Medema R, Blanchard JM, Sardet C, Vignais ML.

Mol Cell Biol. 2001 Apr;21(8):2956-66.


pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F.

Fajas L, Paul C, Zugasti O, Le Cam L, Polanowska J, Fabbrizio E, Medema R, Vignais ML, Sardet C.

Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7738-43.


[The Blm(-/-) mice: an stage towards the understanding the molecular mechanisms at play in Bloom syndrome].

Vignais ML.

Bull Cancer. 1999 Mar;86(3):249. French. No abstract available.


[Ski and SnoN: antagonistic proteins of TGFbeta signaling].

Vignais ML.

Bull Cancer. 2000 Feb;87(2):135-7. Review. French.


Differential effect of Rac and Cdc42 on p38 kinase activity and cell cycle progression of nonadherent primary mouse fibroblasts.

Philips A, Roux P, Coulon V, Bellanger JM, Vié A, Vignais ML, Blanchard JM.

J Biol Chem. 2000 Feb 25;275(8):5911-7.


[Smad3-/- mice: a murine model for the study of human colorectal cancers?].

Vignais ML.

Bull Cancer. 1998 Dec;85(12):989-90. French. No abstract available.


[Cyclin A: a good markers for the study of cell cycle control and tumor progression?].

Philips A, Huet X, Plet A, Rech J, Vignais ML, Vié A, Blanchard JM.

C R Seances Soc Biol Fil. 1998;192(2):223-30. Review. French.


Characterization of Escherichia coli strains with gapA and gapB genes deleted.

Seta FD, Boschi-Muller S, Vignais ML, Branlant G.

J Bacteriol. 1997 Aug;179(16):5218-21.


Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.

Vignais ML, Sadowski HB, Watling D, Rogers NC, Gilman M.

Mol Cell Biol. 1996 Apr;16(4):1759-69.


Contacts between the factor TUF and RPG sequences.

Vignais ML, Huet J, Buhler JM, Sentenac A.

J Biol Chem. 1990 Aug 25;265(24):14669-74.


Asymmetric DNA bending induced by the yeast multifunctional factor TUF.

Vignais ML, Sentenac A.

J Biol Chem. 1989 May 25;264(15):8463-6.


The yeast H+-ATPase gene is controlled by the promoter binding factor TUF.

Capieaux E, Vignais ML, Sentenac A, Goffeau A.

J Biol Chem. 1989 May 5;264(13):7437-46.


Specific binding of TUF factor to upstream activation sites of yeast ribosomal protein genes.

Vignais ML, Woudt LP, Wassenaar GM, Mager WH, Sentenac A, Planta RJ.

EMBO J. 1987 May;6(5):1451-7.


A general upstream binding factor for genes of the yeast translational apparatus.

Huet J, Cottrelle P, Cool M, Vignais ML, Thiele D, Marck C, Buhler JM, Sentenac A, Fromageot P.

EMBO J. 1985 Dec 16;4(13A):3539-47.

Supplemental Content

Loading ...
Support Center